The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 16, 2021

Filed:

Jun. 26, 2019
Applicant:

The Regents of the University of California, Oakland, CA (US);

Inventors:

Thomas J. Kipps, San Diego, CA (US);

Bradley T. Messmer, San Diego, CA (US);

Ana B. Sanchez, Encinitas, CA (US);

Andrew C. Kummel, San Diego, CA (US);

Manuel Ruidiaz, La Jolla, CA (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/543 (2006.01); G01N 33/68 (2006.01); G01N 33/94 (2006.01); G01N 33/537 (2006.01); G01N 33/577 (2006.01); G01N 33/58 (2006.01);
U.S. Cl.
CPC ...
G01N 33/6854 (2013.01); G01N 33/537 (2013.01); G01N 33/54326 (2013.01); G01N 33/577 (2013.01); G01N 33/582 (2013.01); G01N 33/94 (2013.01);
Abstract

Complexes comprising a therapeutic monoclonal antibody and a peptide are provided. In some embodiments, the complexes may comprise a therapeutic monoclonal antibody which is not complexed to an epitope of a target protein and a peptide complexed to the therapeutic monoclonal antibody. In some embodiments, the peptide may have a length of about 5-40 amino acids and may comprise a mimetope recognized by the therapeutic monoclonal antibody, wherein the mimetope comprises a linear sequence of amino acids which is different than a linear sequence of amino acids in the epitope of the target protein.


Find Patent Forward Citations

Loading…